Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Blend · Elevation

SRH U.S. Quality GARP ETF (SRHQ)

Ticker SRHQ · Since 2022-10-04 · · Holdings as of Jul 31, 2026

Expense ratio
0.35%$35/yr per $10k
1-yr return
+7.2%as of Dec 2025
Net assets
$212.2Mall share classes
Holdings
81

Bottom line

Is SRHQ a good fund? The bottom line

SRHQ is an actively managed large blend ETF from Elevation.

It charges 0.35% — about $35 a year on every $10,000 invested, cheaper than 86% of large blend funds we track.

It returned +7.2% over one year (as of Dec 31, 2025, per its prospectus).

With $212 million in net assets and 81 holdings, its largest position is Humana Inc (2.3%) and the top 10 make up 18.2% of the portfolio.

What stands out

  • Low cost: cheaper than 86% of large blend peers

Updated Nov 19, 2026

What SRHQ invests in

The SRH U.S. Quality GARP ETF (the Fund) seeks to provide investment results (before fees and expenses) that correspond to the SRH U.S. Quality GARP Index (the Index).

The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The SRH U.S. Quality GARP Index The Index is intended to capture the performance of U.S. companies that exhibit consistent and moderate revenue growth but do not trade at excessive valuations. The creator of the Index, SRH Advisors, LLC (the Index Provider), has designed the Index to provide exposure to a diversified portfolio of U.S. companies featuring value, growth, and quality characteristics while maintaining overall market exposure close to that of widely-followed, broad-based U.S. equity benchmarks. The Index is constructed through the application of an objective, rules-based methodology created by the Index Provider, which involves first defining the investable universe of securities, then screening the securities in the investable universe using value, growth…

From the fund's prospectus (filed Feb 27, 2026).

SRHQ performance

Fund calendar-year total returns, 2024–2025 2024: +16.5%; 2025: +7.2% +16.5% 2024 +7.2% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
SRHQ+7.2%——
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full SRHQ performance history →

What SRHQ costs

On a $10,000 investment, SRHQ's 0.35% expense ratio costs about $35 a year. The prospectus estimates $443 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full SRHQ fee table →

SRHQ top 10 holdings

#Holding% of fund
1Humana Inc HUM2.31%
2Centene Corp CNC2.09%
3Insperity Inc NSP2.06%
4Qualys Inc QLYS1.81%
5Nutanix Inc NTNX1.71%
6UnitedHealth Group Inc UNH1.69%
7Commvault Systems Inc CVLT1.67%
8Amneal Pharmaceuticals Inc AMRX1.62%
9Sterling Infrastructure Inc STRL1.61%
10Gen Digital Inc GEN1.61%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 18.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to SRHQ

More funds like SRHQ →

SRHQ FAQ

What is the expense ratio of SRHQ?
SRHQ's expense ratio is 0.35%, which works out to about $35 a year for every $10,000 invested. The prospectus estimates total costs of $443 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is SRHQ a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 86% of large blend peers. This is general information, not personalized advice.
What does SRHQ hold?
SRHQ's largest holdings are Humana Inc (2.3%), Centene Corp (2.1%), Insperity Inc (2.1%), Qualys Inc (1.8%), Nutanix Inc (1.7%). It holds 81 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages SRHQ?
SRHQ is offered by Elevation through Elevation Series Trust.